Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Augmenting Response to Entecavir Using a Temporary Peginterferon Alpha-2a Add-on Strategy for the Treatment of HBeAg-Positive Chronic Hepatitis B.

Trial Profile

Augmenting Response to Entecavir Using a Temporary Peginterferon Alpha-2a Add-on Strategy for the Treatment of HBeAg-Positive Chronic Hepatitis B.

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 09 Nov 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Entecavir (Primary) ; Peginterferon alfa-2a (Primary)
  • Indications Hepatitis B
  • Focus Therapeutic Use
  • Acronyms ARES
  • Most Recent Events

    • 01 Feb 2019 Results of post hoc analysis of two international RCTs (NCT00877760 and NCT01532843) published in the Alimentary Pharmacology and Therapeutics
    • 01 Jul 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 13 Nov 2012 Interim results for 160 patients at 48 weeks presented at the 63rd Annual Meeting of the American Association for the Study of Liver Diseases.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top